activins and Carcinoma, Renal Cell

activins has been researched along with Carcinoma, Renal Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Behrens, J; Wacker, I1
Akçetin, Z; Behrens, J; Huber, O; Knaup, K; Sachs, M; Wacker, I; Weiske, J; Wiesener, M1
Alves, F; Augustin, HG; Dullin, C; Kimmina, S; Krneta, J; Kroll, J; Phillips, DJ; Prahst, C; Sananbenesi, F1

Other Studies

3 other study(ies) available for activins and Carcinoma, Renal Cell

ArticleYear
Activin B antagonizes RhoA signaling to stimulate mesenchymal morphology and invasiveness of clear cell renal cell carcinomas.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Actins; Activins; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Knockdown Techniques; HEK293 Cells; Humans; Kidney Neoplasms; Mesoderm; Models, Biological; Neoplasm Invasiveness; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; Serum; Signal Transduction; Stress Fibers

2014
Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor.
    Molecular and cellular biology, 2009, Volume: 29, Issue:7

    Topics: Activins; Animals; Carcinoma, Renal Cell; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Transformation, Neoplastic; Extracellular Matrix; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Rats; RNA, Small Interfering; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays

2009
Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.
    Cancer research, 2006, Jun-01, Volume: 66, Issue:11

    Topics: Activins; Animals; Apoptosis; Breast Neoplasms; Carcinoma, Renal Cell; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Follistatin; Humans; Kidney Neoplasms; Mice; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Transfection; Transplantation, Heterologous

2006